AMPEAK ENERGY LIMITED – Results Of Agm
RNS Number : 1643M Ampeak Energy Limited 14 July 2026 14 July 2026 AMPEAK ENERGY LIMITED (“Ampeak Energy”,
RNS Number : 1643M Ampeak Energy Limited 14 July 2026 14 July 2026 AMPEAK ENERGY LIMITED (“Ampeak Energy”,
RNS Number : 8490J Ampeak Energy Limited 26 June 2026 26 June 2026 AMPEAK ENERGY LIMITED (“Ampeak Energy”,
Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces its audited results for the year ended 31 December 2017.
Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses,announces that 8,896,034 shares in Partner Company, Motif Bio plc, have been sold directly to a leading US institutional investor at 31 pence per share.
Amphion Innovations plc, the developer of medical and technology businesses, is pleased to announce today that its wholly-owned subsidiary, DataTern Inc., has received from the United States Patent and Trademark Office (“USPTO”) a Notice of Intent to Issue Ex Parte Reexamination Certificate confirming the patentability of the original 20 claims of the U.S. Patent No. 5,937,402 (“402”) as well as three clarifying patent claims added during the reexamination. This determination by the USPTO is an important part of further validating our outstanding patents.